🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsTirzepatide (Mounjaro / Zepbound)Mounjaro savings card update — July 2024 Page 4

Mounjaro savings card update — July 2024

tammy_FL Wed, Feb 7, 2024 at 5:59 PM 60 replies 3,510 viewsPage 4 of 12
newstart_MO
New Member
12
45
Feb 2026
Springfield, MO
Feb 8, 2024 at 9:33 PM#16

From the other side of the consultation, briefly. The useful move here is to separate what is established from what is widely repeated. Those two sets overlap less than the confident tone of most write-ups suggests, and the second set is where nearly all the disagreement on this board comes from.

I would rather be corrected than agreed with, if it comes to it.

5 3bri_stats, pete_manc_UK, anna.melb_AU and 2 others
Reply Quote Save Share Report
mel_PDX
Member
189
890
Dec 2024
Portland, OR
Feb 8, 2024 at 11:42 PM#17

One thing that is still open after bri_stats’s answer:

What would you measure differently if you were starting again?

6 4Dr.KarenChen, Dr.NateNeph, PharmD_Rodriguez and 3 others
Reply Quote Save Share Report
Dr.Martinez
Medical Advisor
3,891
28,456
Nov 2023
Boston, MA
Online
Feb 9, 2024 at 1:51 AM#18
newstart_MO said:
The useful move here is to separate what is established from what is widely repeated.

Filing a mild objection. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit. The counter-case has not been addressed. Somebody upthread described the situation that does not fit, and the thread moved on rather than engaging with it, which is the failure mode this board is supposed to avoid.

7 5rachel_ABQ, traveltech_sara, AttorneyGrant and 4 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
tommy_boulder
Member
234
1,123
Nov 2024
Boulder, CO
Feb 9, 2024 at 4:00 AM#19
newstart_MO said:
The useful move here is to separate what is established from what is widely repeated.

Correct, and worth adding that it is reversible. Nothing being described here is a one-way door, which changes how cautious it is reasonable to be.

8 6dan_philly, MeganSA_TX, LarryQC_SD and 5 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Feb 9, 2024 at 6:08 AM#20

Moderator note: two posts asking for a source have been merged into one. Please search the thread before asking again. Carry on.

30 3PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 27 others
Reply Quote Save Share Report

Similar Threads

SURMOUNT-5: Tirzepatide vs semaglutide head-to-head — full results11 replies
SURPASS 1-5 program: tirzepatide T2DM efficacy data compilation6 replies
Tirzepatide dual agonism: GIP + GLP-1 synergistic mechanism18 replies
5mg → 10mg → 15mg titration — clinical guidance and real-world data8 replies
Zepbound insurance coverage — payer-by-payer breakdown 20268 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register